Delivery Order SPE2DB20D1100-SPE2DB24FC5P3

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,711.02, is for the delivery of Kisqali 200 mg daily dose pharmaceuticals. The contract has an ultimate completion date of July 9, 2024 and is a firm fixed price delivery order. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $59,141.73 Firm Fixed Price delivery order contract is for the pharmaceutical product KISQALI 400 MG DAILY DOSE 42S. The contract has an ultimate completion date of February 18, 2025 and was awarded on February 14, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $14,856.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product KISQALI 600 MG DAILY DOSE 63S, with an ultimate completion date of March 24, 2025. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,362.48, is for the delivery of the medication KISQALI 600 MG DAILY DOSE 63S. This is a Firm Fixed Price delivery order contract with a completion date of June 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,716.15 Firm Fixed Price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $10,266.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $39,734.24, is for the delivery of the drug Kisqali 600 mg daily dose in 63-count bottles. The contract is a firm fixed-price delivery order with a period of performance ending on February 18, 2025. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $14,643.18. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,196.55 Firm Fixed Price Delivery Order contract is to supply the drug Kisqali 200 mg daily dose. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen is the prime contractor, and there is no indication of any set-aside requirements for this award. AmerisourceBergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,548.98 firm fixed-price delivery order is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5P3
    Delivery Order

This federal contract award, valued at $48,349.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Kisqali 600 mg daily dose 63s, a specialty medication. The contract is a firm fixed-price Delivery Order with a period of performance through July 3, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:42 AM